Cargando…

Effects of Gold Fiducial Marker Implantation on Tumor Control and Toxicity in External Beam Radiotherapy of Prostate Cancer

BACKGROUND: Evidence regarding the effects of fiducials in image-guided radiotherapy (IGRT) for tumor control and acute and late toxicity is sparse. PATIENTS AND METHODS: Patients with primary low- and intermediate-risk prostate cancer, 40 with and 21 without gold fiducial markers (GFM), and treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moll, Matthias, Weiß, Magdalena, Stanisav, Vladimir, Zaharie, Alexandru, Goldner, Gregor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039472/ https://www.ncbi.nlm.nih.gov/pubmed/36653352 http://dx.doi.org/10.2478/raon-2023-0004

Ejemplares similares

Treatment of low-risk prostate cancer: a retrospective study with 477 patients comparing external beam radiotherapy and I-125 seeds brachytherapy in terms of biochemical control and late side effects
por: Moll, Matthias, et al.
Publicado: (2020)

Clinical outcome in metastatic prostate cancer after primary radiotherapy
por: Moll, Matthias, et al.
Publicado: (2022)

Biochemical control after adjuvant radiation therapy for prostate cancer: a unicentric, retrospective analysis
por: Zaharie, Alexandru-Teodor, et al.
Publicado: (2021)

Advancements in the radiooncological Treatment of High-risk Prostate Cancer: A Quarter Century of Achievements
por: Moll, Matthias, et al.
Publicado: (2022)

Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer
por: Moll, Matthias, et al.
Publicado: (2021)

A clinical study comparing polymer and gold fiducials for prostate cancer radiotherapy
por: Lim Joon, Daryl, et al.
Publicado: (2023)

Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy
por: Maspero, Matteo, et al.
Publicado: (2018)

Infections after fiducial marker implantation for prostate radiotherapy: are we underestimating the risks?
por: Loh, Jasmin, et al.
Publicado: (2015)

Prostate deformation during hypofractionated radiotherapy: an analysis of implanted fiducial marker displacement
por: Knybel, Lukas, et al.
Publicado: (2021)

Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy
por: Moll, Matthias, et al.
Publicado: (2022)

Fiducial markers in prostate cancer image-guided radiotherapy
por: Ghaffari, Hamed, et al.
Publicado: (2019)

Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
por: D’Avino, Vittoria, et al.
Publicado: (2015)

Recommendation of fiducial marker implantation for better target tracking using MV imager in prostate radiotherapy
por: Ma, Tianjun, et al.
Publicado: (2018)

Transperineal implantation of gold fiducial markers (gold seeds) for prostate image‐guided radiation therapy: a feasible technique associated with a low risk of complications
por: Saad, Akram, et al.
Publicado: (2015)

Potentials of on-line repositioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapy
por: Graf, Reinhold, et al.
Publicado: (2009)

Intra-prostatic gold fiducial marker insertion for image-guided radiotherapy (IGRT): five-year experience on 795 patients
por: Mahdavi, Ali, et al.
Publicado: (2023)

Hypofractionated External-Beam Radiotherapy for Prostate Cancer
por: Cho, L. Chinsoo, et al.
Publicado: (2013)

External beam radiotherapy for localized prostate cancer
por: Yilmaz, Hasan, et al.
Publicado: (2015)

Dose reduction potential of using gold fiducial markers for kilovoltage image‐guided radiotherapy
por: Takei, Yoshiki, et al.
Publicado: (2020)

Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers
por: Skarsgard, David, et al.
Publicado: (2010)

Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI
por: Pathmanathan, Angela U., et al.
Publicado: (2019)

Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

Comparison of treatment costs for primary localized prostate cancer in Austria and Vienna: an economic analysis
por: Moll, Matthias, et al.
Publicado: (2023)

Comparison of kV Orthogonal Radiographs and kV-Cone-Beam Computed Tomography Image-Guided Radiotherapy Methods With and Without Implanted Fiducials in Prostate Cancer
por: Eren, Mehmet F, et al.
Publicado: (2020)

Exploratory models comparing ethiodized oil-glue and gold fiducials for bladder radiotherapy image-guidance
por: Lim Joon, Daryl, et al.
Publicado: (2021)

A phantom study to contrast and compare polymer and gold fiducial markers in radiotherapy simulation imaging
por: Lim Joon, Daryl, et al.
Publicado: (2021)

Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging
por: Osman, Sarah O. S., et al.
Publicado: (2019)

Prostate only radiotherapy using external beam radiotherapy: A clinician’s perspective
por: Lee, Jeong Won, et al.
Publicado: (2022)

Postoperative radiotherapy for prostate cancer: Morbidity of local-only or local-plus-pelvic radiotherapy
por: Waldstein, Cora, et al.
Publicado: (2017)

Nanofabrication of a gold fiducial array on specimen support for electron tomography
por: Koning, Roman I., et al.
Publicado: (2013)

Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity
por: Miszczyk, Marcin, et al.
Publicado: (2023)

Biochemical failure and toxicity in treatment with brachytherapy and external beam radiotherapy compared with radical prostatectomy in localized prostate cancer
por: Galdos-Bejar, Marcelo, et al.
Publicado: (2022)

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer
por: Phak, Jeong Hoon, et al.
Publicado: (2016)

Observed high incidence of prostatic calculi with the potential to act as natural fiducials for prostate image guided radiotherapy
por: O'Neill, A.G.M., et al.
Publicado: (2019)

Intraprostatic fiducial markers: a potential application for ultrasound-guided radiotherapy in prostate cancer
por: Vavassori, A, et al.
Publicado: (2009)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
por: Guo, Yadong, et al.
Publicado: (2019)

Quantification of Nanoscale Dose Enhancement in Gold Nanoparticle-Aided External Photon Beam Radiotherapy
por: Vlastou, Elena, et al.
Publicado: (2022)

Using C‐Arm X‐ray images from marker insertion to confirm the gold fiducial marker identification in an MRI‐only prostate radiotherapy workflow
por: Gustafsson, Christian, et al.
Publicado: (2018)

Cardiac embolization of an implanted fiducial marker for hepatic stereotactic body radiotherapy: a case report
por: Hennessey, Hooman, et al.
Publicado: (2009)

Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
por: Cella, Laura, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_blrt6812c2l3s014islcu9bbe3